Elisa Sensi Selected Research

Elisa Sensi Research Topics

Disease

10	Neoplasms (Cancer) 06/2021 - 11/2003
8	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 09/2010
2	Adenocarcinoma of Lung 01/2019 - 10/2014
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2012
2	Melanoma (Melanoma, Malignant) 01/2017 - 04/2015
2	Papillary Thyroid Cancer 05/2016 - 09/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2014 - 06/2014
2	Breast Neoplasms (Breast Cancer) 12/2010 - 10/2006
1	Proctitis 01/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2019
1	Disease Progression 01/2019
1	Hand-Foot Syndrome 01/2019
1	Anaplastic Thyroid Carcinoma 01/2019
1	Malignant Mesothelioma 01/2017
1	Mesothelioma 01/2017
1	Lymphadenopathy 01/2017
1	Carcinogenesis 01/2017
1	Adenoma (Adenomas) 05/2016
1	Lung Neoplasms (Lung Cancer) 11/2014
1	Lymphoma (Lymphomas) 11/2014
1	Sarcoma (Soft Tissue Sarcoma) 05/2014
1	Febrile Neutropenia 09/2010
1	Hypertension (High Blood Pressure) 09/2010
1	Lymphatic Metastasis 09/2010
1	Dehydration (Water Stress) 09/2010
1	Stomatitis 09/2010

Drug/Important Bio-Agent (IBA)

5	Bevacizumab (Avastin)FDA Link 01/2019 - 09/2010
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 09/2010
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 09/2010
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 09/2010
2	ParaffinIBA 06/2021 - 04/2015
2	Formaldehyde (Formol)FDA Link 06/2021 - 04/2015
2	Capecitabine (Xeloda)FDA Link 01/2019 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 04/2015
2	Monoclonal AntibodiesIBA 04/2015 - 05/2014
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 11/2003
2	Biomarkers (Surrogate Marker)IBA 09/2014 - 04/2014
2	ErbB Receptors (EGF Receptor)IBA 09/2014 - 05/2014
2	LigandsIBA 09/2014 - 01/2012
1	prolinedithiocarbamate (PDTC)IBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	crenolanibIBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	MitogensIBA 01/2017
1	trametinibIBA 01/2017
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	CateninsIBA 05/2016
1	Connective Tissue Growth FactorIBA 05/2016
1	Metalloproteases (Metalloproteinases)IBA 05/2016
1	L-SelectinIBA 05/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2016
1	IntegrinsIBA 05/2016
1	OsteopontinIBA 05/2016
1	ThrombospondinsIBA 05/2016
1	CollagenIBA 05/2016
1	Laminin (Merosin)IBA 05/2016
1	Cadherins (E-Cadherin)IBA 05/2016
1	Fibronectins (Fibronectin)IBA 05/2016
1	Lysine (L-Lysine)FDA Link 11/2015
1	Enhancer of Zeste Homolog 2 ProteinIBA 11/2015
1	Histones (Histone)IBA 11/2015
1	Leucovorin (Folinic Acid)FDA Link 10/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2015
1	CrizotinibIBA 11/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2014
1	PlatinumIBA 10/2014
1	Tyrosine Kinase InhibitorsIBA 10/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2014
1	Cetuximab (Erbitux)FDA Link 09/2014
1	Anaplastic Lymphoma KinaseIBA 06/2014
1	CarbonIBA 04/2014
1	Chemokine ReceptorsIBA 01/2012
1	Codon (Codons)IBA 12/2010
1	Capsules (Microcapsules)IBA 09/2010
1	imidazole mustard (BIC)IBA 10/2006

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2019 - 10/2014
2	Therapeutics 01/2019 - 05/2014
1	Neoadjuvant Therapy 01/2019
1	Chemoradiotherapy 01/2019
1	Salvage Therapy 10/2014